REFERENCES
- Ayd FJ Jr: A survey of drug-induced extrapyramidal reactions. JAMA 175: 1054–1060, 1961
- Hollister LE: Complications from psychotherapeutic drugs. I. N Engl J Med 264: 291–293, 1961
- Hollister LE, Caffey EM Jr, Klett CJ: Abnormal symptoms, signs, and laboratory tests during treatment with phenothiazine derivatives. Clin Pharmacol Ther 1: 284–293, 1960
- Faurbye A, Rasch PJ, Petersen PB, et al: Neurological symptoms in pharmacotherapy of psychoses. Acta Psychiatr Scand 40: 10–27, 1964
- Sigwald J, Bouttier D, Raymondeaud C, et al: Quatre cas de dyskinésie facio-bucco-linguo-masticative à évolution prolongée secondaire à un traitement par les neuroleptiques. Rev Neurol 100: 751–755, 1959
- Crane GE: Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am J Psychiatry 124: 40–48, Suppl, Feb 1968
- Crane GE: Dyskinesia and neuroleptics. Arch Gen Psychiatry 19: 700–703, 1968
- Schmidt WR, Jarcho LW: Persistent dyskinesias following phenothiazine therapy. Report of five cases and a review of the literature. Arch Neurol 14: 369–377, 1966
- Villeneuve A, Böszörményi Z: Treatment of drug-induced dyskinesias. Lancet 1: 353–354, 14 Feb 1970
- Kline NS: On the rarity of “irreversible” oral dyskinesias following phenothiazines. Am J Psychiatry 124: 48–54, 1968
- Mueller RA, Thoenen H, Axelrod J: Increase in tyrosine hydroxylase activity after reserpine administration. J Pharmacol Exp Ther 169: 74, 1969
- Cotzias GC, Van Woert MH, Schiffer LM: Aromatic amino acids and modification of parkinsonism. N Engl J Med 276: 374, 1967
- Yahr MD: Abnormal involuntary movements induced by dopa: clinical aspects. In Barbeau A, McDowell FH (Editors): L-Dopa and Parkinsonism. Philadelphia, FA Davis Company, 1970, pp 101–108
- McDowell FH: Dyskinetic movements. Ibid,13 pp 108–109
- Carlsson A: Biochemical implications of dopa-induced actions on the central nervous system, with particular reference to abnormal movements. Ibid,13 pp 205–213
- Lewis PD, Harrison MJ: Involuntary movements in patients taking oral contraceptives. Br Med J 4: 404–405, 1969